Morgan Stanley raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $462 from $459 and keeps an Equal Weight rating on the ...

Vertex Pharmaceuticals will not advance clinical trials of a treatment for Type 1 diabetes after efficacy data failed to support further clinical advancement.

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...

Vertex Solutions, a small business known for the manufacturing of systems integration and advanced training technologies, has been awarded a contract to deliver 25 additional T-38 Gen 2 enhanced ...

Zacks Research has upped the financial bar for Vertex Pharmaceuticals, boosting its 2026 earnings forecast from $16.18 to $16 ...

Vertex Pharmaceuticals has been the apple of investors' search engines, but its recent stock dip of 3.3% might have folks ...

Download and save the PDF to your computer Open the downloaded PDF in Acrobat Reader 10 or later Fill out this worksheet to calculate your GST/HST new housing rebate.